Prednisolone treatment was found to upregulate the Mamstr gene in dystrophin-deficient mouse muscle compared to untreated controls (Chadwick et al., 2016) and upregulate Myh and dystrophin in human DMD primary culture (Sklar and Brown, 1991). Here, DMD is linked to Duchenne muscular dystrophy.